Effect of probiotics on the maintenance of intestinal homeostasis after chemotherapy: systematic review and meta-analysis of pre-clinical studies
äºBeneficial MicrobesSearch for other papers by W.G. Lima in
Current site
Google Scholar
Search for other papers by R.M. Pessoa in
Current site
Google Scholar
Search for other papers by K.D. Vital in
Current site
Google Scholar
Search for other papers by I.K.T.M. Takenaka in
Current site
Google Scholar
Search for other papers by V.N. Cardoso in
Current site
Google Scholar
Search for other papers by S.O.A. Fernandes in
Current site
Google Scholar
Gastrointestinal mucositis (GIM) is an inflammation caused by antitumor therapy, especially after chemotherapy and radiotherapy. Currently in the clinical practice, only palliative measures are taken to treat GIM, representing the main clinical limitation in the management of this condition. Several studies have highlighted the potential benefits of probiotics for the management of GIM, but the actual role of these microorganisms in the maintenance of intestinal homeostasis remains elusive. In this context, here we aimed to realise a systematic review with meta-analysis to evaluate the effect of probiotics on experimental GIM. The meta-analysis showed that probiotics significantly suppressed the body weight loss related to GIM in rodents (95% confidence interval (CI): -2.67 to -0.70; I2=98%, P<0.00). Subgroup analysis showed that pre-treatment (â¥7 days before chemotherapy) (95% CI: -8.84 to -0.17; I2=98%, P<0.04) with a high dose of probiotics (⥠109 cfu/day) (95% CI: -2.58 to -0.28; I2=98%, P<0.00) comprising two or more microorganism species (95% CI: -6.49 to -0.28; I2=96%, P=0.03) remedied GIM more effectively. It was also revealed that fungi (specifically Saccharomyces boullardii) are more effective in remedying GIM than bacteria (P=0.03 vs P<0.00), and the mouse models are more receptive than rats to the enteroprotective effects of probiotics (95% CI: -4.76, -0.69; I2=97%, P=0.01). Qualitative analyses highlighted that probiotics suppress GIM through several mechanisms; they reduce the intestinal permeability, suppress the pro-inflammatory cytokine production while stimulating production and secretion of anti-inflammatory cytokines, inhibit the signalling pathways coupled to inflammation and apoptosis, accelerate the proliferation of enterocytes, reduce the levels of reactive oxygen species, and help maintain the protective mucus layer. In conclusion, this review highlights the therapeutic benefits of probiotics in experimental GIM.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Andrade, M.E.R., Araújo, R.S., de Barros, P.A.V., Soares, A.D.N., Abrantes, F.A., Generoso, S.d.V., Fernandes, S.O.A. and Cardoso, V.N., 2015. The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clinical Nutrition 34: 1080-1087. https://doi.org/10.1016/j.clnu.2015.01.012
-
Azaïs-Braesco, V., Bresson, J.L., Guarner, F. and Corthier, G., 2010. Not all lactic acid bacteria are probiotics, â¦but some are. British Journal of Nutrition 103: 1079-1081. https://doi.org/10.1017/S0007114510000723
-
Bastos, R.W., Pedroso, S.H.S.P., Vieira, A.T., Moreira, L.M.C., França, C.S., Cartelle, C.T., Arantes, R.M.E., Generoso, S.V., Cardoso, V.N., Neves, M.J., Nicoli, J.R. and Martins, F.S., 2016. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis. Beneficial Microbes 7: 549-557. https://doi.org/10.3920/BM2015.0190
-
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F. and Collins, S.M., 2011. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599-609.e593. https://doi.org/10.1053/j.gastro.2011.04.052
-
Bertolini, M., Sobue, T., Thompson, A. and Dongari-Bagtzoglou, A., 2017. Chemotherapy induces oral mucositis in mice without additional noxious stimuli. Translational Oncology 10: 612-620. https://doi.org/10.1016/j.tranon.2017.05.001
-
Bowen, J.M., Stringer, A.M., Gibson, R.J., Yeoh, A.S.J., Hannam, S. and Keefe, D.M.K., 2007. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss. Cancer Biology and Therapy 6: 1445-1450. https://doi.org/10.4161/cbt.6.9.4622
-
Carvalho, R.D., Breyner, N., Menezes-Garcia, Z., Rodrigues, N.M., Lemos, L., Maioli, T.U., da Gloria Souza, D., Carmona, D., de Faria, A.M.C., Langella, P., Chatel, J.-M., Bermúdez-Humarán, L.G., Figueiredo, H.C.P., Azevedo, V. and de Azevedo, M.S., 2017. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microbial Cell Factories 16: 27. https://doi.org/10.1186/s12934-017-0624-x
-
Cereda, E., Caraccia, M. and Caccialanza, R., 2018. Probiotics and mucositis. Current Opinion in Clinical Nutrition and Metabolic Care 21: 399-404. https://doi.org/10.1097/MCO.0000000000000487
-
Chang, C.-W., Liu, C.-Y., Lee, H.-C., Huang, Y.-H., Li, L.-H., Chiau, J.-S.C., Wang, T.-E., Chu, C.-H., Shih, S.-C., Tsai, T.-H. and Chen, Y.-J., 2018. Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model. Frontiers in Microbiology 9. https://doi.org/10.3389/fmicb.2018.00983
-
Cinausero, M., Aprile, G., Ermacora, P., Basile, D., Vitale, M.G., Fanotto, V., Parisi, G., Calvetti, L. and Sonis, S.T., 2017. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Frontiers in Pharmacology 8. https://doi.org/10.3389/fphar.2017.00354
-
Ciorba, M.A. and Stenson, W.F., 2009. Probiotic therapy in radiation-induced intestinal injury and repair. Annals of the New York Academy of Sciences 1165: 190-194. https://doi.org/10.1111/j.1749-6632.2009.04029.x
-
Ciorba, M.A., Hallemeier, C.L., Stenson, W.F. and Parikh, P.J., 2015. Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action. Current Opinion in Supportive and Palliative Care 9: 157-162. https://doi.org/10.1097/spc.0000000000000134
-
Clinicaltrials.Gov, 2019. Available at: https://clinicaltrials.gov/.
-
Cruchet, S., Furnes, R., Maruy, A., Hebel, E., Palacios, J., Medina, F., Ramirez, N., Orsi, M., Rondon, L., Sdepanian, V., Xóchihua, L., Ybarra, M. and Zablah, R.A., 2015. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Pediatric Drugs 17: 199-216. https://doi.org/10.1007/s40272-015-0124-6
-
Deeks, J.J., Higgins, J. and Altman, D.G., 2011. Analysing data and undertaking meta-analyses. In: Higgins, J.P.T. and Green, S. (eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, London, UK.
'Analysing data and undertaking meta-analyses', ().
-
Del Piano, M., Carmagnola, S., Andorno, S., Pagliarulo, M., Tari, R., Mogna, L., Strozzi, G.P., Sforza, F. and Capurso, L., 2010. Evaluation of the intestinal colonization by microencapsulated probiotic bacteria in comparison with the same uncoated strains. Journal of Clinical Gastroenterology 44: S42-S46. https://doi.org/10.1097/MCG.0b013e3181ed0e71
-
Dinan, T.G., Stanton, C. and Cryan, J.F., 2013. Psychobiotics: a novel class of psychotropic. Biological Psychiatry 74: 720-726. https://doi.org/10.1016/j.biopsych.2013.05.001
-
Dörr, W., Spekl, K. and Martin, M., 2002. Radiation-induced oral mucositis in mice: strain differences. Cell Proliferation 35: 60-67. https://doi.org/10.1046/j.1365-2184.35.s1.6.x
-
Eriksen, M.B. and Frandsen, T.F, 2018. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. Journal of the Medical Library Association 106: 420-431. https://doi.org/10.5195/jmla.2018.345.
-
Fijan, S., 2014. Microorganisms with Claimed probiotic properties: an overview of recent literature. International Journal of Environmental Research and Public Health 11. https://doi.org/10.3390/ijerph110504745
-
Floch, M.H., Walker, W.A., Madsen, K., Sanders, M.E., Macfarlane, G.T., Flint, H.J., Dieleman, L.A., Ringel, Y., Guandalini, S., Kelly, C.P. and Brandt, L.J., 2011. Recommendations for probiotic use â 2011 update. Journal of Clinical Gastroenterology 45: S168-S171. https://doi.org/10.1097/MCG.0b013e318230928b
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/zdbrkeg.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514. https://doi.org/10.1038/nrgastro.2014.66
-
Huang, L., Chiang Chiau, J.-S., Cheng, M.-L., Chan, W.-T., Jiang, C.-B., Chang, S.-W., Yeung, C.-Y. and Lee, H.-C., 2019. SCID/NOD mice model for 5-FU induced intestinal mucositis: safety and effects of probiotics as therapy. Pediatrics and Neonatology 60: 252-260. https://doi.org/10.1016/j.pedneo.2018.07.007
-
Jiang, C., Wang, H., Xia, C., Dong, Q., Chen, E., Qiu, Y., Su, Y., Xie, H., Zeng, L., Kuang, J., Ao, F., Gong, X., Li, J. and Chen, T., 2019. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. Cancer 125: 1081-1090. https://doi.org/10.1002/cncr.31907
-
Justino, P.F.C., Melo, L.F.M., Nogueira, A.F., Costa, J.V.G., Silva, L.M.N., Santos, C.M., Mendes, W.O., Costa, M.R., Franco, A.X., Lima, A.A., Ribeiro, R.A., Souza, M.H.L.P. and Soares, P.M.G., 2014. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. British Journal of Nutrition 111: 1611-1621. https://doi.org/10.1017/S0007114513004248
-
Justino, P.F.C., Melo, L.F.M., Nogueira, A.F., Morais, C.M., Mendes, W.O., Franco, A.X., Souza, E.P., Ribeiro, R.A., Souza, M.H.L.P. and Soares, P.M.G., 2015. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice. Cancer Chemotherapy and Pharmacology 75: 559-567. https://doi.org/10.1007/s00280-014-2663-x
-
Kato, S., Hamouda, N., Kano, Y., Oikawa, Y., Tanaka, Y., Matsumoto, K., Amagase, K. and Shimakawa, M., 2017. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. Clinical and Experimental Pharmacology and Physiology 44: 1017-1025. https://doi.org/10.1111/1440-1681.12792
-
Kutylowksi, J. and Yahia, N., 2019. Types, frequency, duration, and dosage of probiotics to prevent necrotizing enterocolitis in preterm infants among countries. Advances in Neonatal Care 19: 188-197. https://doi.org/10.1097/anc.0000000000000605
-
Lalla, R.V., Sonis, S.T. and Peterson, D.E., 2008. Management of oral mucositis in patients who have cancer. Dental Clinics of North America 52: 61-77. https://doi.org/10.1016/j.cden.2007.10.002
-
Landis, J.R. and Koch, G.G., 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159-174.Larsen, N., Vogensen, F.K., Gøbel, R.J., Michaelsen, K.F., Forssten, S.D., Lahtinen, S.J. and Jakobsen, M., 2013. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clinical Nutrition 32: 935-940. https://doi.org/10.1016/j.clnu.2013.02.007
-
Lee, H.-R., Yoo, N., Kim, J.H., Sohn, K.-Y., Kim, H.-J., Kim, M.-H., Han, M.Y., Yoon, S.Y. and Kim, J.W., 2016. The therapeutic effect of PLAG against oral mucositis in hamster and mouse model. Frontiers in Oncology 6. https://doi.org/10.3389/fonc.2016.00209
-
Levit, R., Savoy de Giori, G., de Moreno de LeBlanc, A. and LeBlanc, J.G., 2018a. Folate-producing lactic acid bacteria reduce inflammation in mice with induced intestinal mucositis. Journal of Applied Microbiology 125: 1494-1501. https://doi.org/10.1111/jam.14038
-
Levit, R., Savoy de Giori, G., de Moreno de LeBlanc, A. and LeBlanc, J.G., 2018b. Protective effect of the riboflavin-overproducing strain Lactobacillus plantarum CRL2130 on intestinal mucositis in mice. Nutrition 54: 165-172. https://doi.org/10.1016/j.nut.2018.03.056
-
Li, H.-L., Lu, L., Wang, X.-S., Qin, L.-Y., Wang, P., Qiu, S.-P., Wu, H., Huang, F., Zhang, B.-B., Shi, H.-L. and Wu, X.-J., 2017. Alteration of gut microbiota and inflammatory cytokine/chemokine profiles in 5-fluorouracil induced intestinal mucositis. Frontiers in Cellular and Infection Microbiology 7. https://doi.org/10.3389/fcimb.2017.00455
-
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., Devereaux, P.J., Kleijnen, J. and Moher, D., 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 6: e1000100. https://doi.org/10.1371/journal.pmed.1000100
-
Lin, X.B., Dieleman, L.A., Ketabi, A., Bibova, I., Sawyer, M.B., Xue, H., Field, C.J., Baracos, V.E. and Gänzle, M.G., 2012. Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PloS One 7: e39764. https://doi.org/10.1371/journal. pone.0039764
-
Linn, Y.H., Thu, K.K. and Win, N.H.H., 2019. Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study. Probiotics and Antimicrobial Proteins 11: 638-647. https://doi.org/10.1007/s12602-018-9408-9
-
Logan, R.M., Stringer, A.M., Bowen, J.M., Gibson, R.J., Sonis, S.T. and Keefe, D.M.K., 2009. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemotherapy and Pharmacology 63: 239-251. https://doi.org/10.1007/s00280-008-0732-8
-
Maioli, T.U., de Melo Silva, B., Dias, M.N., Paiva, N.C., Cardoso, V.N., Fernandes, S.O., Carneiro, C.M., dos Santos Martins, F. and de Vasconcelos Generoso, S., 2014. Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. Journal of Negative Results in Biomedicine 13: 6. https://doi.org/10.1186/1477-5751-13-6
-
Mauger, C.A., Butler, R.N., Geier, M.S., Tooley, K.L. and Howarth, G.S., 2007. Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Digestive Diseases and Sciences 52: 612-619. https://doi.org/10.1007/s10620-006-9464-y
-
McCullough, R.W., 2017. US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncology 13: 2823-2852. https://doi.org/10.2217/fon-2017-0418
-
McFarland, L.V., 2015. From yaks to yogurt: the history, development, and current use of probiotics. Clinical Infectious Diseases 60: S85-S90. https://doi.org/10.1093/cid/civ054
-
Mego, M., Chovanec, J., Vochyanova-Andrezalova, I., Konkolovsky, P., Mikulova, M., Reckova, M., Miskovska, V., Bystricky, B., Beniak, J., Medvecova, L., Lagin, A., Svetlovska, D., Spanik, S., Zajac, V., Mardiak, J. and Drgona, L., 2015. Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complementary Therapies in Medicine 23: 356-362. https://doi.org/10.1016/j.ctim.2015.03.008
-
Mi, H., Dong, Y., Zhang, B., Wang, H., Peter, C.C.K., Gao, P., Fu, H. and Gao, Y., 2017. Bifidobacterium infantis ameliorates chemotherapy-induced intestinal mucositis via regulating T cell immunity in colorectal cancer rats. Cellular Physiology and Biochemistry 42: 2330-2341. https://doi.org/10.1159/000480005
-
Mortensen, H.R., Overgaard, J., Specht, L., Overgaard, M., Johansen, J., Evensen, J.F., Andersen, L.J., Andersen, E. and Grau, C., 2012. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. Radiotherapy and Oncology 103: 69-75. https://doi.org/10.1016/j.radonc.2012.01.002
-
Murphy, B.A., 2007. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. Journal of Supportive Oncology 5: 13-21.
'Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy ' () 5 Journal of Supportive Oncology : 13 -21.
-
Naidu, M.U.R., Ramana, G.V., Rani, P.U., Mohan, l.K., Suman, A. and Roy, P., 2004. Chemotherapy-induced and/or radiation therapy-induced oral mucositis-complicating the treatment of cancer. Neoplasia 6: 423-431. https://doi.org/10.1593/neo.04169
-
Oh, N.S., Lee, J.Y., Lee, J.M., Lee, K.W. and Kim, Y., 2017. Mulberry leaf extract fermented with Lactobacillus acidophilus A4 ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Letters in Applied Microbiology 64: 459-468. https://doi.org/10.1111/lam.12741
-
Piano, M.D., Carmagnola, S., Ballarè, M., Balzarini, M., Montino, F., Pagliarulo, M., Anderloni, A., Orsello, M., Tari, R., Sforza, F., Mogna, L. and Mogna, G., 2012. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form. Journal of Clinical Gastroenterology 46: S85-S92. https://doi.org/10.1097/MCG.0b013e3182672796
-
Plaza-DÃaz, J., Ruiz-Ojeda, J.F., Vilchez-Padial, M.L. and Gil, A., 2017. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9. https://doi.org/10.3390/nu9060555
-
Quaresma, M.P., 2016. Lactobacillus spp. e Bifidobacterium sp. atenuam mucosite intestinal experimental induzida por 5-fluorouracil em camundongos. Projeto. Universidade Federal do Ceará.
'Lactobacillus spp', ().
-
Raber-Durlacher, J.E., Elad, S. and Barasch, A., 2010. Oral mucositis. Oral Oncology 46: 452-456.
'Oral mucositis ' () 46 Oral Oncology : 452 -456.
-
Ritchie, M.L. and Romanuk, T.N., 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PloS One 7: e34938. https://doi.org/10.1371/journal.pone.0034938
-
Sanders, M.E., Merenstein, D.J., Reid, G., Gibson, G.R. and Rastall, R.A., 2019. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology and Hepatology 16: 605-616. https://doi.org/10.1038/s41575-019-0173-3
-
Sezer, A., Usta, U. and Cicin, I., 2009. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea. Medical Oncology 26: 350-357. https://doi.org/10.1007/s12032-008-9128-1
-
Shin, W. and Kim, H.J., 2018. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proceedings of the National Academy of Sciences of the USA 115: E10539. https://doi.org/10.1073/pnas.1810819115
-
Smith, C.L., Geier, M.S., Yazbeck, R., Torres, D.M., Butler, R.N. and Howarth, G.S., 2008. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutrition and Cancer 60: 757-767. https://doi.org/10.1080/01635580802192841
-
Sonis, S.T. and Villa, A., 2018. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis. Expert Opinion on Investigational Drugs 27: 147-154. https://doi.org/10.1080/13543784.2018.1427732
-
Sonis, S.T., 2004. Pathobiology of mucositis. Seminars in Oncology Nursing 20: 11-15. https://doi.org/10.1053/j.soncn.2003.10.003
-
Southcott, E., Tooley, K.L., Howarth, G.S., Davidson, G.P. and Butler, R.N., 2008. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Digestive Diseases and Sciences 53: 1837. https://doi.org/10.1007/s10620-008-0275-1
-
Stringer, A.M., Gibson, R.J., Bowen, J.M., Logan, R.M., Ashton, K., Yeoh, A.S.J., Al-Dasooqi, N. and Keefe, D.M.K., 2009. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. International Journal of Experimental Pathology 90: 489-499. https://doi.org/10.1111/j.1365-2613.2009.00671.x
-
Tang, Y., Wu, Y., Huang, Z., Dong, W., Deng, Y., Wang, F., Li, M. and Yuan, J., 2017. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats. Nutrition 33: 96-104. https://doi.org/10.1016/j.nut.2016.05.003
-
Thomsen, M., Clarke, S. and Vitetta, L., 2018. The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments. Beneficial Microbes 9: 899-916. https://doi.org/10.3920/BM2017.0172
-
Tooley, K.L., Howarth, G.S., Lymn, K.A., Lawrence, A. and Butler, R.N., 2006. Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biology and Therapy 5: 593-600. https://doi.org/10.4161/cbt.5.6.2659
-
Tooley, K.L., Howarth, G.S., Lymn, K.A., Lawrence, A. and Butler, R.N., 2011. Oral ingestion of Streptococcus thermophilus does not affect mucositis severity or tumor progression in the tumor-bearing rat. Cancer Biology and Therapy 12: 131-138. https://doi.org/10.4161/cbt.12.2.15720
-
Touchefeu, Y., Montassier, E., Nieman, K., Gastinne, T., Potel, G., Bruley des Varannes, S., Le Vacon, F. and de La Cochetière, M.F., 2014. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis â current evidence and potential clinical applications. Alimentary Pharmacology and Therapeutics 40: 409-421. https://doi.org/10.1111/apt.12878
-
Van Niel, C.W., 2005. Probiotics: not just for treatment anymore. Pediatrics 115: 174. https://doi.org/10.1542/peds.2004-2356
-
Vanhoecke, B. and Stringer, A., 2015. Host-microbe cross talk in cancer therapy. Current Opinion in Supportive and Palliative Care 9: 174-181. https://doi.org/10.1097/spc.0000000000000133
-
Vanhoecke, B., Bateman, E., Mayo, B., Vanlancker, E., Stringer, A., Thorpe, D. and Keefe, D., 2015. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art. Experimental Biology and Medicine 240: 725-741. https://doi.org/10.1177/1535370215581309
-
Viet, C.T., Corby, P.M., Akinwande, A. and Schmidt, B.L., 2014. Review of preclinical studies on treatment of mucositis and associated pain. Journal of Dental Research 93: 868-875. https://doi.org/10.1177/0022034514540174
-
Villa, A. and Sonis, S.T., 2015. Mucositis: pathobiology and management. Current Opinion in Oncology 27: 159-164. https://doi.org/10.1097/cco.0000000000000180
-
Wang, H., Brook, C.L., Whittaker, A.L., Lawrence, A., Yazbeck, R. and Howarth, G.S., 2013. Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis. Scandinavian Journal of Gastroenterology 48: 959-968. https://doi.org/10.3109/00365521.2013.812142
-
Wang, Y., Wu, Y., Wang, Y., Xu, H., Mei, X., Yu, D., Wang, Y. and Li, W., 2017. Antioxidant properties of probiotic bacteria. Nutrients 9. https://doi.org/10.3390/nu9050521
-
Wardill, H.R., Van Sebille, Y.Z.A., Ciorba, M.A. and Bowen, J.M., 2018. Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis. Current Opinion in Supportive and Palliative Care 12: 187-197. https://doi.org/10.1097/spc.0000000000000338
-
Whitford, E.J., Cummins, A.G., Butler, R.N., Prisciandaro, L.D., Fauser, J.K., Yazbeck, R., Lawrence, A., Cheah, K.Y., Wright, T.H., Lymn, K.A. and Howarth, G.S., 2009. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU). Cancer Biology and Therapy 8: 505-511. https://doi.org/10.4161/cbt.8.6.7594
-
Yeung, C.-Y., Chan, W.-T., Jiang, C.-B., Cheng, M.-L., Liu, C.-Y., Chang, S.-W., Chiang Chiau, J.-S. and Lee, H.-C., 2015. Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PloS One 10: e0138746. https://doi.org/10.1371/journal.pone.0138746
-
Yuan, K.T., Yu, H.L., Feng, W.D., Chong, P., Yang, T., Xue, C.L., Yu, M. and Shi, H.P., 2015. Bifidobacterium infantis has a beneficial effect on 5-fluorouracil-induced intestinal mucositis in rats. Beneficial Microbes 6: 113-118. https://doi.org/10.3920/BM2013.0095
-
Zaylaa, M., Al Kassaa, I., Alard, J., Peucelle, V., Boutillier, D., Desramaut, J., Dabboussi, F., Pot, B. and Grangette, C., 2018. Probiotics in IBD: Combining in vitro and in vivo models for selecting strains with both anti-inflammatory potential as well as a capacity to restore the gut epithelial barrier. Journal of Functional Foods 47: 304-315. https://doi.org/10.1016/j.jff.2018.05.029
Supplementary Materials
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 735 | 300 | 15 |
| å ¨ææµè§æ¬¡æ° | 19 | 5 | 0 |
| PDFä¸è½½æ¬¡æ° | 29 | 3 | 0 |
Effect of probiotics on the maintenance of intestinal homeostasis after chemotherapy: systematic review and meta-analysis of pre-clinical studies
äºBeneficial MicrobesSearch for other papers by W.G. Lima in
Current site
Google Scholar
PubMed
Search for other papers by R.M. Pessoa in
Current site
Google Scholar
PubMed
Search for other papers by K.D. Vital in
Current site
Google Scholar
PubMed
Search for other papers by I.K.T.M. Takenaka in
Current site
Google Scholar
PubMed
Search for other papers by V.N. Cardoso in
Current site
Google Scholar
PubMed
Search for other papers by S.O.A. Fernandes in
Current site
Google Scholar
PubMed
Gastrointestinal mucositis (GIM) is an inflammation caused by antitumor therapy, especially after chemotherapy and radiotherapy. Currently in the clinical practice, only palliative measures are taken to treat GIM, representing the main clinical limitation in the management of this condition. Several studies have highlighted the potential benefits of probiotics for the management of GIM, but the actual role of these microorganisms in the maintenance of intestinal homeostasis remains elusive. In this context, here we aimed to realise a systematic review with meta-analysis to evaluate the effect of probiotics on experimental GIM. The meta-analysis showed that probiotics significantly suppressed the body weight loss related to GIM in rodents (95% confidence interval (CI): -2.67 to -0.70; I2=98%, P<0.00). Subgroup analysis showed that pre-treatment (â¥7 days before chemotherapy) (95% CI: -8.84 to -0.17; I2=98%, P<0.04) with a high dose of probiotics (⥠109 cfu/day) (95% CI: -2.58 to -0.28; I2=98%, P<0.00) comprising two or more microorganism species (95% CI: -6.49 to -0.28; I2=96%, P=0.03) remedied GIM more effectively. It was also revealed that fungi (specifically Saccharomyces boullardii) are more effective in remedying GIM than bacteria (P=0.03 vs P<0.00), and the mouse models are more receptive than rats to the enteroprotective effects of probiotics (95% CI: -4.76, -0.69; I2=97%, P=0.01). Qualitative analyses highlighted that probiotics suppress GIM through several mechanisms; they reduce the intestinal permeability, suppress the pro-inflammatory cytokine production while stimulating production and secretion of anti-inflammatory cytokines, inhibit the signalling pathways coupled to inflammation and apoptosis, accelerate the proliferation of enterocytes, reduce the levels of reactive oxygen species, and help maintain the protective mucus layer. In conclusion, this review highlights the therapeutic benefits of probiotics in experimental GIM.
| å ¨é¨æé´ | è¿å»ä¸å¹´ | è¿å»30天 | |
|---|---|---|---|
| æè¦æµè§æ¬¡æ° | 735 | 300 | 15 |
| å ¨ææµè§æ¬¡æ° | 19 | 5 | 0 |
| PDFä¸è½½æ¬¡æ° | 29 | 3 | 0 |
